JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Issues journals
Medical Radiology and Radiation Safety. 2020. Vol. 65. No. 2. P. 57–61
V.V. Fedorov, V.I. Potetnya, A.S. Moiseev, A.E. Chernukha, S.E. Ulyanenko, A.N. Solovev
Mathematical Simulation of the Doses inside Patient Body under Prostate Irradiation with Carbon Ion Beam
A. Tsyb Medical Radiological Research Center — branch of the National Medical Research Radiological Center of the
Ministry of Health of the Russian Federation, Obninsk, Kaluga region
E-mail:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: The radiotherapy methods using heavy charged particles become popular nowadays due to its high efficiency in treatment of oncological patients. On the other side, the practical application of such particles is deeply connected to the influence of secondary radiation, which is a result of nuclear collisions, that can affect the patients’ tissues and organs outside the treatment field. Doses in the out-of-field volumes should be considered from the standpoint of radiological protection. In this study we perform mathematical simulations of the absorbed dose in various organs under the prostate irradiation with carbon ion beam and compared these dose values with existing reference values from CT procedures, and known radiological protection recommendations against current practice of clinical use of carbon ions.
Material and methods: The simulation tool is general application Monte-Carlo code FLUKA widely used for ionizing radiation transport modeling and simulations in radiological protection field. The patient model is one of the most detailed voxelized anthropomorphic phantom Vishum. During the simulation the absorbed dose of segmented organs has been assessed under the spread-out Bragg peak of carbon ions uniformly covering the prostate with the physical dose. The resulted dose in organs is normalized to the prostate dose. This is the qualitative assessment of radiation treatment procedure which allowed us to analyze the out-of-field doses in distant organs from the viewpoint of radiological protection in ion beam therapy, following existing ICRP Publication 127 guidelines.
Results: The results show that the levels of dose due to prostate irradiation in the regimes widely used in the world practice are two level of magnitude lower than dose levels under the full body CT examination, and are comparable to the aircraft crew doses.
Conclusion: Thus, the obtained results might be interested from the risks assessment point of view, including the secondary radiation-induced cancers or other observable or expected treatment effects.
Key words: Monte-Carlo simulation, ion beam therapy, dose distribution, anthropomorphic phantom, voxel phantom, prostate, secondary radiation, spread-out Bragg peak
For citation: Fedorov VV, Potetnya VI, Moiseev AS, Chernukha AE, Ulyanenko SE, Solovev AN. Mathematical Simulation of the Doses inside Patient Body under Prostate Irradiation with Carbon Ion Beam. Medical Radiology and Radiation Safety. 2020;65(2):57-61. (In Russ.).
DOI: 10.12737/1024-6177-2020-65-2-57-61
References
1. Каприн АД, Ульяненко СЕ. Адронная терапия — точки развития. Медицина: целевые проекты. 2016;23:56-59. [Kaprin AD, Ulyanenko SE. Hadron therapy — development points. Medicine: Target Projects. 2016;23:56-59. (in Russ.)].
2. Соловьев АН, Гулидов ИА, Мардынский ЮС, Ульяненко СЕ и др. Современные тенденции в мире частиц. Краткие итоги конференции PTCOG56. Радиационная биология. Радиоэкология. 2017;57(5):548-50. [Soloviev AN, Gulidov IA, Mardynsky YuS, Ulyanenko SE, Galkin VN, Kaprin AD. Modern Trends in the World of Particles. Summary results of the PTCOG56 Conference. Radiation Biology. Radioecology. 2017;57(5):548-50. (in Russ.)].
3. Durante M, Paganetti H. Nuclear physics in particle therapy: a review. Reports on Progress in Physics. 2016;79:096702 DOI: 10.1088/0034-4885/79/9/096702.
4. Grassberger C, Paganetti H. Elevated LET components in clinical proton beams. Phys Med Biol. 2011;56:6677-91. DOI: 10.1088/0031-9155/56/20/011.
5. Ульяненко СЕ, Лычагин АА, Корякин СН, Чернуха АЕ, и др. Распределение дозы и ЛПЭ в биообъектах при облучении протонами. Медицинская физика. 2018;1(77):68-74. [Ulyanenko SE, Lychagin AA, Koryakin SN, Chernukha AE, Troshina MV, Goulidov IN, et al. Simulation of dose and LET distributions within biological objects in proton fields. Medical Physics. 2018;1(77):68-74. (in Russ.)].
6. Polf JC, Newhauser WD, Titt U. Patient neutron dose equivalent exposures outside of the proton therapy treatment field. Radiat Protect Dosimetry. 2005;115:154-8.
7. Zacharatou J, Lee C, Bolch C, Xu W, Paganetti H. Assessment of organ specific neutron doses in proton therapy using whole-body age-dependent voxel phantoms. Phys Med Biol. 2008;53:693-714. DOI: 10.1088/0031-9155/53/3/012.
8. Корякина ЕВ, Потетня ВИ. Цитогенетические эффекты низких доз нейтронов в клетках млекопитающих. Альманах клинической медицины. 2015;41:72-8. [Koryakina EV, Potetnya VI. Cytogenetic effects of low neutron doses in mammalian cells. Almanac of Clinical Medicine. 2015;41:72-8. (in Russ.)].
9. Gunzert-Marx K, Iwase H, Schardt D, Simon RS. Secondary beam fragments produced by 200 MeV 12C ions in water and their dose contributions in carbon ion radiotherapy. New J Phys. 2008;10:075003. DOI: 10.1088/1367-2630/10/7/075003.
10. Iwase H, Gunzert-Marx K, Haettner E, Schardt D, Gutermuth F, Kraemer M, et al. Experimental and theoretical study of the neutron dose produced by carbon ion therapy beams. Radiat Protect Dosimetry. 2007;126(1-4):615-8.
11. Hultqvist M, Gudowska I. Secondary doses delivered to an anthropomorphic male phantom under prostate irradiation with proton and carbon ion beams Radiat Measurements. 2010;45:1410-3. DOI: 10.1016/j.radmeas.2010.05.020.
12. Hultqvist M, Gudowska I. Secondary absorbed doses from light ion irradiation in anthropomorphic phantoms representing an adult male and a 10 year old child. Phys Med Biol. 2010;55:6633-53. DOI: 10.1088/0031-9155/55/22/004.
13. Xu XG, Bednarz B, Paganetti H. A review of dosimetry studies on external beam radiation treatment with respect to second cancer induction. Phys Med Biol. 2008;53(13):193-241. DOI: 10.1088/0031-9155/53/13/R01.
14. ICRP. Radiological Protection in Ion Beam Radiotherapy. ICRP Publication 127. Annals of the ICRP. 2014;43(4)
15. Zankl M, Fill U, Petoussi-Henss N, Regulla D. Organ dose conversion coefficients for external photon irradiation of male and female voxel models. Phys Med Biol. 2002;47:2367-85.
16. Ballarini F, Battistoni G, Campanella M, Carboni M, Cerutti F, Empl A, et al. The FLUKA code: an overview. J Phys: Conference Series. 2006;41:151-60.
17. Schlattl H, Zankl M, Becker J, Hoeschen C. Dose conversion coefficients for CT examinations of adults with automatic tube current modulation. Phys Med Biol. 2010;55(20):6243-61. DOI: 10.1088/0031-9155/55/20/013.
18. ICRU. Reference Data for the Validation of Doses from Cosmic-Radiation Exposure of Aircraft Crew. ICRU Report 84 (prepared jointly with ICRP). ICRU. 2010;10(2).
19. Osama M, Sishc BJ, Saha J, Pompos A, Rahimi A, Story M, et al. Carbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/Repair. Cancers. 2017;9(66) DOI: 10.3390/cancers9060066.
20. Антипов ЮМ, Бритвич ГИ, Иванов СВ, Костин МЮ, и др. Формирование поперечно-плоского дозового поля и первые радиобиологические эксперименты на углеродном пучке, выведенном из У-70. Приборы и техника эксперимента. 2015;58(4):107-16. DOI: 10.7868/S0032816215040011 [Antipov YM, Britvich GI, Ivanov SV, Kostin MY, Lebedev OP, Lyudmirskii EA, et al. Transversally-flat dose field formation and primary radiobiological exercises with the carbon beam extracted from the U-70 synchrotron. Instruments and Experimental Techniques. 2015;58(4):552-61. DOI: 10.1134/S0020441215040016. (in Russ.)].
21. Бекетов ЕЕ, Исаева ЕВ, Трошина МВ, Лычагин АА, и др. Результаты предварительных исследований биологической эффективности пучка ионов углерода ускорителя У-70. Радиационная биология. Радиоэкология. 2017;57(5):462-70 [Beketov EE, Isaeva EV, Troshina MV, Lychagin AA, Solovev AN, Koryakin SN, et al. Results of the Preliminary Study on the Evaluation of the Biological Effectiveness of Carbon Ion Beam from U-70 Accelerator. Radiation Biology. Radioecology. 2017;57(5):462-70. DOI: 10.7868/S0869803117050022. (in Russ.)].
22. Каприн АД, Галкин ВН, Жаворонков ЛП, Иванов ВК и др. Синтез фундаментальных и прикладных исследований — основа обеспечения высокого уровня научных результатов и внедрения их в медицинскую практику. Радиация и риск. 2017;26(2):26-40. DOI: 10.21870/0131-3878-2017-26-2-26-40 [Kaprin AD, Galkin VN, Zhavoronkov LP, Ivanov VK, Ivanov SA, Romanko YuS. Synthesis of basic and applied research is the basis of obtaining high-quality findings and translating them into clinical practice. Radiation and Risk. 2017;26(2):26-40. DOI: 10.21870/0131-3878-2017-26-2-26-40. (in Russ.)].
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 04.02.2019.
Accepted for publication: 12.03.2020.
Medical Radiology and Radiation Safety. 2020. Vol. 65. No. 2. P. 62–67
P.O. Rumiantsev1, A.A. Trukhin1,2, K.A. Sergunova3, Ya.I. Sirota1, N.M. Makarova1,2, А.А. Bubnov2, D.S. Semenov3, E.S. Ahmad3
Phantoms for Nuсlear Medicine
1 National Medical Research Centre of Endocrinology, Moscow, Russia,
This email address is being protected from spambots. You need JavaScript enabled to view it.
2 National Research Nuclear University MEPhI, Moscow, Russia
3 Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies, Moscow Healthcare Department, Moscow, Russia
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
The nuclear medicine phantom development is based on the step by step description of the computational and experimental biological object model. Computational phantoms are used for geometry of the object description and simulate physics of particle interactions with matter, while experimental phantoms are used for quality control tests and standardization of functional research protocols. Common examples are the dosimetry planning of radionuclide therapy and post-therapeutic scintigraphy with 131I. This review provides a list of methods for computational and experimental phantoms. Examples of existing phantoms created for the nuclear medicine tasks are also given.
Key words: nuclear medicine, theranostics, phantom, mathematical phantom, experimental phantom, 3D print, quantitative dosimetry
For citation: Rumiantsev PO, Trukhin AA, Sergunova KA, Sirota YaI, Makarova NM, Bubnov АА, Semenov DS, Ahmad ES. Phantoms for Nuсlear Medicine. Medical Radiology and Radiation Safety. 2020;65(2):62-7. (In Russ.).
DOI: 10.12737/1024-6177-2020-65-2-62-67
References
- Larry A. The Phantoms of Medical and Health Physics. Springer. 2014; 290.
- Sidney Y. Handbook of Materials Modeling. Springer. 2005; 2965.
- Климанов ВА. Радиобиологическое и дозиметрическое планирование лучевой и радионуклидной терапии. Часть 1: учеб. пособие для вузов.— М.: НИЯУ МИФИ, 2011. 604 c. [Klimanov VA. Radiobiological and Dosimetric Planning in Radionuclide Therapy. Part 1: Student book. Moscow. 2011; 604. (in Russ.)].
- Camoni L. Quality Control of Nuclear Medicine Instrumentation and Protocol Standardisation. EANM 2017; 168.
- Xu XG. Handbook of Anatomical Models for Radiation Dosimetry. CRC Press. 2009; 757.
- Bailey L, Willowson K. An Evidence-Based Review of Quantitative SPECT Imaging and Potential Clinical Applications. J Nucl Med. 2013;54(83):9.
- Jan S, Santin G, Strul D. Users Guide V8.0 Introduction [internet source] URL:http://wiki.opengatecollaboration.org/index.php?title=Users_Guide_V8.0&oldid=910.
- Sun R, Limkin EJ, Dercle L. Computational medical imaging (radiomics) and potential for immuno-oncology. Journal de la Societe francaise de radiotherapie oncologique. 2017; 648-54.
- International Atomic Energy Agency. Quality Assurance for SPECT Systems. IAEA Human Health Series. Vienna, Austria. 2009;6:263.
- International Atomic Energy Agency. Planning a Clinical PET Centre. IAEA Human Health Series. Vienna, Austria. 2010;11:160.
- Busemann E, Płachcínska A, Britten A. Routine quality control recommendations for nuclear medicine instrumentation. Eur J Nucl Med Mol Imaging. 2010;37:662-71.
- International Atomic Energy Agency. Clinical PET/CT Atlas: A Casebook of Imaging in Oncology. IAEA Human Health Series. IAEA. 2015; 201.
- Khalil M, Tremoleda J, Bayomy T. Molecular SPECT Imaging: An Overview. Int J Mol Imaging. 2011; 15.
- Арсвольд Д. Эмиссионная томография: основы ПЭТ и ОФЭКТ. Учеб. пособие для выпускников вузов. М.: Техносфера, 2009. 599 с. [Arsvold D. Emision tomography: basics of PET and SPECT. Technosphere. 2009; 599. (in Russ.)].
- Agostinelli AG, Smolen SD, Nath RA. New water-equivalent plastic for dosimetry calibration. Med Phys. 1992;19:774.
- Tello VM, Tailor RC, Hanson WF. How water equivalent are water-equivalent plastics for output calibration of photon and electron beams? Med Phys. 1995;22:1177-89.
- Селиванов МГ, Александрук АГ, Четвериков СФ, Пономарев АС. О возможности использования пластинчатого тканеэквивалентного фантома для верификации дозового распределения в лучевой терапии. Казань: Бук. 2017:30-3. [Selivanov MG, Aleksandruk AG, Chetverikov SF. On the possibility of using a lamellar tissue equivalent phantom to verify the dose distribution in radiation therapy. Buk. 2017: 30-3. (in Russ.)].
- Whole Body Phantom PBU-60 [internet source]. URL: https://www.kyotokagaku.com/products/detail03/ph-2b.html.
- Modular Full Body X-Ray Phantom [internet source]. URL: https://www.erler-zimmer.de/shop/en/medical-simulators/x-ray-ct/10180/modular-full-body-x-ray-phantom.
- Anthtopomorhic phantoms [internet source]. URL: http://rsdphantoms.com/rdanth.htm.
- Mitsouras D, Liacouras P, Imanzadeh A. Medical 3D Printing for the Radiologist. Radiographics In Press. 2015;7:1965-87.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 03.06.2019.
Accepted for publication: 12.03.2020.
Medical Radiology and Radiation Safety. 2020. Vol. 65. No. 2. P. 82–86
A.D. Ryzhkov1, A.S. Krylov1, A.B. Bludov1, A.V. Kuzin2, S.M. Kaspshik1, M.B. Dolgushin1
Evaluation of the SPECT/CT Method in the Diagnosis of Alkaptonuric Ochronosis. Clinical Case
1 N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia
2 Russian Medical Academy of Continuous Professional Education, Moscow, Russia
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: Is to demonstrate functional and structural changes in the musculoskeletal system of the patient with alkaptonuric ochronosis using bone scan and hybrid imaging consisting of single-photon emission computed tomography (SPECT) and X-ray transmission computed tomography (CT) scan (SPECT/CT).
Material and methods: A clinical case report of patient with alkaptonuric ochronosis, examined with bone scan and SPECT/CT.
Results: In this article we show a clinical case with the picture of mineral metabolism disorder and severe degenerative changes of musculoskeletal system in patient with alkaptonuric ochronosis (a genetically determined disease), caused by metabolic disorders of tyrosine. We used hybrid SPECT/CT method for evaluation of this disease.
Conclusion: SPECT/CT method demonstrated structural and metabolic changes. This method allowed us to reveal the specific changes in cases of alkaptonuric ochronosis, but also it shows the possibility of using radionuclide methods in solving non-standard situations, while this method has not previously been applied.
Key words: alkaptonuria, ochronosis, bone scan, SPECT/CT
For citation: Ryzhkov AD, Krylov AS, Bludov AB, Kuzin AV, Kaspshik SM, Dolgushin MB. Evaluation of the SPECT/CT Method in the Diagnosis of Alkaptonuric Ochronosis. Clinical Case. Medical Radiology and Radiation Safety. 2020;65(2):82-6. (In Russ.).
DOI: 10.12737/1024-6177-2020-65-2-82-86
References
- Mannoni A, Selvi E, Lorenzini S, Giorgi M, Airó P, Cammelli D, Andreotti L, Marcolongo R, Porfirio B. Alkaptonuria, ochronosis, and ochronotic arthropathy. Semin Arthritis Rheum. 2004;33(4):239-48. DOI: 10.1053/s0049-0172(03)00080-5.
- Zatkova A. An update on molecular genetics of Alkaptonuria (AKU). J Inherit Metab Dis. 2011;34(6):1127-36. DOI: 10.1007/s10545-011-9363-z.
- Taylor AM, Boyde A, Wilson PJ, Jarvis JC, Davidson JS, Hunt JA, Ranganath LR, Gallagher JA. The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum. 2011;63(12):3887-96. DOI: 10.1002/art.30606.
- Araki K, Sudo A, Hasegawa M, Uchida A. Devastating ochronotic arthropathy with successful bilateral hip and knee arthroplasties. J Clin Rheumatol. 2009;15(3):138-40. DOI: 10.1097/RHU.0b013e31819e6b41.
- Aquaron R. Alkaptonuria: a very rare metabolic disorder. Indian J Biochem Biophys. 2013;50(5):339-44.
- Gallagher JA, Dillon JP, Sireau N, Timmis O, Ranganath LR. An example of a “fundamental disease” — A rare disease with important lessons for more common disorders. Semin Cell Dev Biol. 2016;52:53-7. DOI: 10.1016/j.semcdb.2016.02.020.
- Perrone A, Impara L, Bruni A, Primicerio P, Marini M. Radiographic and MRI findings in ochronosis. Radiol Med. 2005;110(4):349-58.
- Doganavsargil B, Pehlivanoglu B, Bicer EK, Argin M, Bingul KB, Sezak M, et al. Black joint and synovia: histopathological evaluation of degenerative joint disease due to ochronosis. Pathol Res Pract. 2015;21(6);470-7. DOI: 10.1016/j.prp.2015.03.001.
- Ranganath LR, Cox TF Natural history of alkaptonuria revisited: analyses based on scoring systems. J Inherit Metab Dis. 2011;34 (6):1141-51. DOI: 10.1007/s10545-011-9374-9.
- Насонова ВА, Бунчук НВ. Руководство для врачей. Ревматические болезни. М.: Медицина. 1997. 520 с. [Nasonova VA, Bunchuk NV (Ed.) Rheumatic Diseases: A Guide for Physicians. M.: Medicine. 1997. 520 p. (in Russ.)].
- Клипелл ДХ, Стоун ДХ, Кроффорд ЛДж, Уайт ПХ. Ревматические заболевания. Руководство в 3 т. Т.2. Заболевания костей и суставов. Под ред. Насонова ЕЛ, Насонова ВА, Олюнина ЮА. (перевод). М.: ГЭОТАР-Медиа. 2012. 520 с. [Clipell DH, Stone DH, Crofford LJ, White PH. Ed by Nasonov EL, Nasonov VA, Olyunin YuA (trans). Rheumatic Diseases. Manual in 3 vol. Vol. 2. Bone and Joint Diseases. M.: GEOTAR-Media, 2012. 520 p. (in Russ.)].
- Башкова ИБ, Кичигин ВА, Безлюдная НВ и др. Охроноз: трудности постановки диагноза в практике врача-клинициста. Трудный пациент. 2016;14(10-11):40-5. [Bashkova IB, Kichigin VA, Bezludnaya NV, Stepanov EG, Kovalev DV, Karpuhin AS, Tarasov AN. Ochronosis: difficulties in diagnosing in clinician’s practice. Difficult Patient. 2016;14(10-11):40-5. (in Russ.)].
- Чепой ВМ. Диагностика и лечение болезней суставов. М.: Медицина. 1990. 304 с. [Chepoy VM. Diagnosis and Treatment of Diseases of the Joints. M.: Medicine. 1990. 304 p. (in Russ.)].
- Григоровский ВВ, Бабко АН. Дифференциальная диагностика и лечение охронотической артропатии (описание клинического случая и современное состояние вопроса). Вестник травматологии и ортопедии им. Н.Н. Приорова. 2006;(4):42-8. [Grigorovskiy VV, Babko AN. Differential Diagnosis and Treatment of Ochronotic Arthropathy. (Case report and current state review). N.N. Priorov Bulletin of Traumatology and Ortopedics. 2006;(4):42-8. (in Russ.)].
- Ventura-Ríos L, Hernández-Díaz C, Gutiérrez-Pérez L, Bernal-González A, Pichardo-Bahena R, Cedeño-Garcidueñas AL, Pineda C. Ochronotic arthropathy as a paradigm of metabolically induced degenerative joint disease. A case-based review. Clin Rheumatol. 2016;35(5):1389-95. DOI: 10.1007/s10067-014-2557-7.
- Башкова ИБ, Кичигин ВА, Шаипов РШ и др. Охроноз как причина вторичного остеоартроза. РМЖ. 2017;25(7):474-80. [Bashkova IB, Kichigin VA, Shaipov RSh, Kryuchkov NA, Bezlyudnaya NV, Didichenko SN, Borisova LV. Ochronosis as a cause of secondary osteoarthrosis. RMJ. 2017;25(7):474-80. (in Russ.)].
- Золовкина АГ, Супрун ЕА, Джухаев ДА и др. Алкаптонурический охроноз при эндопротезировании крупных суставов. Лабораторная служба. 2018;7(3-2):95. [Zolovkina AG, Suprun EA, Dzhukhaev DA, Lobanov MN, Abdaljan AM. Alkaptonuric ochronosis in endoprosthesis replacement of large joints. Laboratory Service. 2018;7(3-2):95. (in Russ.)].
- Zhao BH, Chen BC, Shao DC, Zhang Q Osteoarthritis? Ochronotic arthritis! A case study and review of the literature. Knee Surg Sports Traumatol Arthrosc. 2009;17(7):778-81. DOI: 10.1007/s00167-009-0778-0.
- Авдеева ОС, Беляева ЕА, Дубровина ЮС и др. Вторичный остеоартроз при охронозе в сочетании с остеопорозом. Вестник новых медицинских технологий. 2008;15 (3):90-1. [Avdeeva OS, Belyaeva EA, Dubrovina YuS, Nikishina OA, Savenkova NA, Yushina TA. Secondary osteoarthritis in case of ochronosis combined with osteoporosis. Journal of New Medical Technologies. 2008;15 (3):90-1. (in Russ.)].
- Чернов ВИ, Брагина ОД, Синилкин ИГ и др. Радионуклидная тераностика злокачественных образований. Вестник рентгенологии и радиологии. 2016;97(5):306-13. [Chernov VI, Bragina OD, Sinilkin IG, Medvedeva AA, Zel’chan RV. Radionuclide teranostic of malignancies. Journal of Radiology and Nuclear Medicine. 2016;97(5):306-13. (in Russ.)].
- Крылов АС, Рыжков АД, Щипахина ЯА и др. Роль ОФЭКТ/КТ и МРТ в дифференциальной диагностике поражения скелета (клинический случай). Медицинская радиология и радиационная безопасность. 2019;64(1):69-73. [Krylov AS, Ryzhkov AD, Shchipakhina YA, Nered AS, Bludov AB, Shiryaev SV. The role of SPECT/CT and MRI in the differential diagnosis of skeletal damage (case report). Medical Radiology and Radiation Safety. 2019;64(1):69-73. (in Russ.)]. DOI: 10.12737/article_5c55fb5ef00a68.52703915.
- Рыжков АД, Крылов АС, Блудов АБ, Ширяев СВ. Остеосцинтиграфия и ОФЭКТ/КТ в диагностике различных вариантов метастатического поражения костей. Медицинская радиология и радиационная безопасность. 2018;63(2):41-6. [Ryzhkov AD, Krylov AS, Bludov AB, Shiryaev SV Osteoscintigraphy and SPECT/CT in the diagnosis of various variants of bone metastases. Medical Radiology and Radiation Safety. 2018;63(2):41-6. (in Russ.)]. DOI: 10.12737/article_5ac61fd62feba6.78437892.
- Чернов ВИ, Брагина ОД, Синилкин ИГ и др. Радиоиммунотерапия: современное состояние проблемы. Вопросы онкологии. 2016;62(1):24-30. [Chernov VI, Bragina OD, Sinilkin IG, Medvedeva AA, Zelchan RV. Radioimmunotherapy: Current state of the problem. Problems of Oncology. 2016;62(1):24-30. (in Russ.)].
- Рыжков АД, Крылов АС, Ширяев СВ. Преимущество комбинированной ОФЭКТ/КТ в диагностике метастазов в костях. Медицинская радиология и радиационная безопасность. 2017;62(5):33-9. [Ryzhkov AD, Krylov AS, Shiryaev SV, Shchipakhina YaA, Kochergina NV. The advantage of a combined SPECT/CT in the diagnosis of bone metastases. Medical Radiology and Radiation Safety. 2017;62(5):33-9. (in Russ.)]. DOI: 10.12737/article_59f2fc0812bc46.45377149.
- Chernov VI, Triss SV, Skuridin VS, Lishmanov YB Thallium-199: A new radiopharmaceutical for myocardial perfusion imaging. Int J Card Imaging 1996;12(2):119-26.
- Lishmanov Y, Minin S, Efimova I, Chernov V, Saushkina Y, Lebedev D, Popov S. The possible role of nuclear imaging in assessment of the cardiac resynchronization therapy effectiveness in patients with moderate heart failure. Ann Nucl Med. 2013;27(4):378-85.
PDF (RUS) Full-text article (in Russian)
ORCID authors’
Ryzhkov A.D., http://orcid.org/0000-0002-9571-801X
Krylov A.S., http://orcid.org/0000-0002-8476-7879
Bludov A.B., https://orcid.org/0000-0002-0970-6144
Kuzin A.V., http://orcid.org/0000-0002-1262-932Х
Kaspshik S.M., http://orcid.org/0000-0002-1384-9551
Dolguyshin M.B., http://orcid.org/0000-0003-3930-5998
Conflict of interest. The authors declare no conflict of interest.
Informed consent. All patients signed an informed consent to participate in the study.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 21.01.2020
Accepted for publication: 12.03.2020.
Medical Radiology and Radiation Safety. 2020. Vol. 65. No. 2. P. 68–81
B.Ya. Narkevich1,2, A.V. Khmelev3,4, V.V. Krylov5, T.Yu. Kochetova5
Development of a Concise Glossary of Nuclear Medicine Terms
1 N.N. Blokhin National Medical Research Center for Oncology, Ministry of Health of Russia, Moscow, Russia
2 Association of Medical Physicists of Russia, Moscow, Russia
3 Research Institute — Republican Research Scientific and Consulting Center for Expertise, Moscow, Russia
4 Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia, Moscow, Russia
5 A. Tsyb Medical Radiological Research Center — branch of the National Medical Research Radiological Center of the
Ministry of Health of the Russian Federation, Obninsk, Kaluga region, Russia
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
The development of domestic nuclear medicine necessitates the development and systematization of the most frequently used terms with scientifically based interpretation of their respective concepts. It is important to ensure the correct and unambiguous interpretation of the terms not only by professionals in the field of nuclear medicine, but also by specialists in related fields of knowledge. A short glossary of terms in nuclear medicine is presented, which contains all the most frequently used terms in this field and explanations for each of them, adapted for all the above specialists.
Key words: nuclear medicine, terminology, glossary
For citation: Narkevich BYa, Khmelev AV, Krylov VV, Kochetova TYu. Development of a Concise Glossary of Nuclear Medicine Terms. Medical Radiology and Radiation Safety. 2020;65(2):68-81. (In Russ.).
DOI: 10.12737/1024-6177-2020-65-2-68-81
References
- Наркевич БЯ, Ратнер ТГ, Моисеев АН. Краткий словарь дискуссионных терминов по медицинской радиологии, радиационной безопасности и медицинской физике. Медицинская радиология и радиационная безопасность 2018;63(5):55-64. DOI: 10.12737/article_5bc89734df8824.31259760. [Narkevich BYa, Ratner TG, Moiseev AN. Brief dictionary of discussion terms on medical radiology, radiation safety and medical physics. Medical Radiology and Radiation Safety. 2018;63(5):55-64. (in Russ.)].
PDF (RUS) Full-text article (in Russian)
ORCID authors’
B.Ya. Narkevich http://orcid.org/0000-0002-4293-7358
A.V. Khmelev https://orcid.org/0000-0002-5808-1507
V.V. Krylov https://orcid.org/0000-0001-6655-5592
T.Yu. Kochetova https://orcid.org/0000-0002-7809-1059
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 12.02.2020.
Accepted for publication: 12.03.2020.
Medical Radiology and Radiation Safety. 2020. Vol. 65. No. 2. P. 87




